CRISPR comes to COVID
Friday, July 10, 2020
BE spinout Sherlock Biosciences is using a gene-editing system in coronavirus tests approved for use in health care — the first CRISPR product to reach the market.
BE spinout Sherlock Biosciences is using a gene-editing system in coronavirus tests approved for use in health care — the first CRISPR product to reach the market.